Research and experimental development on natural sciences and engineering
PHARMAQ ANALYTIQ AS
Revenue 2024
NOK 88.6m
Operating profit
NOK −4.6m
Equity
NOK 20.9m
Incorporated
2000
Employees
57
Share capital
NOK 1.1m
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 88.6m | |
| Total operating costs | 93.2m | |
| Operating profit (EBIT) | −4.6m | |
| Net financial items | −680k | |
| Profit for the year | −4.1m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 45.8m | |
| of which current assets | 26.0m | |
| Equity | 20.9m | |
| Total liabilities | 24.9m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.